NXS 6.38% 22.0¢ next science limited

Ann: Appendix 4C & Quarterly Activity Report - 31 December 2023, page-6

  1. 221 Posts.
    lightbulb Created with Sketch. 122
    My hope for this quarterly was:
    1. Revenue guidance achieved.
    2. Negative Operating Cashflow trending down.

    Actual results reflect achievement of revenue guidance (on the lower end), reduction in cash burn and renewed commitment to being cashflow and EBITDA positive in H2 '24.

    I am very happy with these results. Good growth on a PCP and Q on Q basis (despite the impact of the changes made to sales mix in Q3). So to me, the growth sustainability of sales quality have both improved since the arrival of IV Hall.

    '24 Guidance of US$36 - $40m would reflect Revenue growth of between 62 and 80%. These are very good numbers and coupled with the commitment to positive cashflow & EBITDA by 2H '24 leaves me feeling very bullish.
 
watchlist Created with Sketch. Add NXS (ASX) to my watchlist
(20min delay)
Last
22.0¢
Change
-0.015(6.38%)
Mkt cap ! $64.17M
Open High Low Value Volume
22.0¢ 23.5¢ 22.0¢ $11.83K 53.55K

Buyers (Bids)

No. Vol. Price($)
1 7058 22.0¢
 

Sellers (Offers)

Price($) Vol. No.
23.5¢ 8717 2
View Market Depth
Last trade - 16.10pm 01/07/2024 (20 minute delay) ?
NXS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.